Skin News and Research

RSS

Melanin is not only good for you, it also can be bad

Blondes and redheads not only are more susceptible to skin cancer, but the source of their skin and hair pigmentation, melanin, actually magnifies the damaging effects of ultraviolet (UV) rays, according to a study published online this week in the Proceedings of the National Academy of Sciences.

13 Oct 2004

Plastic surgeons successfully perform entire face reconstruction with minimal scarring in a single procedure

A team of plastic surgeons has successfully combined several reconstructive techniques to help burn victims regain some sense of self without undergoing multiple painful procedures and huge scarring often associated with reconstructing the face

13 Oct 2004

Nanotechnology company pSivida granted European patent

Nanotechnology company pSivida has announced that its UK operating subsidiary pSiMedica Limited has been granted a further patent for BioSiliconTM.

13 Oct 2004

Loss of fat and sun exposure play a bigger role than gravity in aging the face

To the surprise of many people, the loss of fat and sun exposure play a bigger role than gravity in aging the face, according to a study presented today at the American Society of Plastic Surgeons (ASPS) Plastic Surgery 2004 conference in Philadelphia.

12 Oct 2004

Researchers suggest how to generate B cells from stem cells

Before stem cells, of whatever origin, can be used to treat patients, scientists will need to learn how to coax them to develop into the desired cell types, a major challenge.

11 Oct 2004

Balanced diet reduces the risk of a baby with spina bifida

According to Dutch researcher Pascal Groenen, a balanced diet reduces the risk of a baby with spina bifida. He investigated how different nutritional components affected the risk of developing this condition.

11 Oct 2004

Wound healers cause skin disease

Dutch researcher Manon Franssen has shown that cells which heal the skin following an injury play an important role in the development of the skin disease psoriasis. In people with psoriasis, the skin peels much faster than normal so that it flakes and becomes inflamed.

11 Oct 2004

Topical nonsteroidal anti-inflammatory drug eases symptoms of osteoarthritis of the knee

Symptoms of primary osteoarthritis of the knee, including pain and stiffness, were significantly improved in patients who used a topical nonsteroidal anti-inflammatory drug (NSAID), according to an article in the October 11 issue of The Archives of Internal Medicine.

11 Oct 2004

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Medical investigators at the Hospital for Special Surgery have identified an important new signaling pathway they believe could be a valuable target for scientists to aim at with future drug therapies that might one day reverse diseases such as systemic lupus erythematosus, according to a recent article published in “Nature Immunology.”

11 Oct 2004

Low-dose estrogen therapy significantly reduced the progression of fatty buildup in the arteries leading to the heart

“We’ve shown that you can get the same reduction in coronary artery atherosclerosis with standard-dose or low-dose estrogen,” said Thomas B. Clarkson, D.V.M., one of the investigators. “It is very significant.”

10 Oct 2004

Massive weight loss patients should be aware that body contouring may require surgeons to address the entire body circumferentially

Many post-bariatric surgery patients experience an extreme loss in skin elasticity that leads them to have body contouring procedures, which greatly differ from contouring procedures performed on normal weight patients.

10 Oct 2004

Barbed sutures, ultrasonic body contouring and soft tissue fillers offer patients faster results without the downtime of surgery

Patients without time for a facelift or intimidated by surgery now have more minimally invasive options that produce effective results.

10 Oct 2004

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

United States Department of Health and Human Services has announced four new contracts totaling more than $232 million to fund development of new vaccines against three potential agents of bioterrorism: smallpox, plague and tularemia. The National Institute of Allergy and Infectious Diseases (NIAID), will administer the contracts.

8 Oct 2004

Discovery of a central memory form of helper T cells that can offer immunity to leishmaniasis

Researchers at the University of Pennsylvania have discovered a "central memory" form of "helper" T cells that can offer immunity to leishmaniasis, a disease that causes considerable death and disfigurement across the globe and has been found in U.S. military personnel returning from Afghanistan and Iraq.

8 Oct 2004

Researchers identify new sulfur-containing scent molecules in sweat

Sometimes, people just don't smell good – and not only in the figurative sense. The sense of smell plays an important role in interpersonal relations.

7 Oct 2004

New medical imaging device will help pinpoint suitable veins for an injection or a drip

The modern technology of light detection using charge coupled device (CCD) TV cameras along with the power of the modern digital computer and state of the art image processing algorithms can be applied to the solution of problems in Medical Imaging.

7 Oct 2004

Half of all Australians still believe a tan is healthy

New research showing half of all Australians still believe a tan is healthy has added to cancer experts’ fears of a prolonged national skin cancer epidemic.

6 Oct 2004

Australian researchers hunt for eczema genes

The Queensland Institute of Medical Research (QIMR) is halfway through a major project examining possible genetic causes of atopic dermatitis which is the most common form of eczema.

6 Oct 2004

EMEA statement following withdrawal of Vioxx (rofecoxib)

EU regulators met with the marketing authorisation holder of Vioxx (rofecoxib), Merck Sharp & Dohme, on 4-5 October 2004 at the informal meeting of the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) held in Scheveningen, The Netherlands.

6 Oct 2004

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

One group of drugs that is effective in fighting HIV may, paradoxically, also be promoting the death of sensory nerves in the skin, according to a study presented October 5, 2004, at the 129th annual meeting of the American Neurological Association in Toronto.

5 Oct 2004

Skin News and Research

Melanin is not only good for you, it also can be bad

Plastic surgeons successfully perform entire face reconstruction with minimal scarring in a single procedure

Nanotechnology company pSivida granted European patent

Loss of fat and sun exposure play a bigger role than gravity in aging the face

Researchers suggest how to generate B cells from stem cells

Balanced diet reduces the risk of a baby with spina bifida

Wound healers cause skin disease

Topical nonsteroidal anti-inflammatory drug eases symptoms of osteoarthritis of the knee

Signaling pathway could be a valuable target for future drug therapies against systemic lupus erythematosus

Low-dose estrogen therapy significantly reduced the progression of fatty buildup in the arteries leading to the heart

Massive weight loss patients should be aware that body contouring may require surgeons to address the entire body circumferentially

Barbed sutures, ultrasonic body contouring and soft tissue fillers offer patients faster results without the downtime of surgery

HHS awards contracts totaling more than $232 million to fund development of new vaccines against smallpox, plague and tularemia

Discovery of a central memory form of helper T cells that can offer immunity to leishmaniasis

Researchers identify new sulfur-containing scent molecules in sweat

New medical imaging device will help pinpoint suitable veins for an injection or a drip

Half of all Australians still believe a tan is healthy

Australian researchers hunt for eczema genes

EMEA statement following withdrawal of Vioxx (rofecoxib)

One group of drugs that is effective in fighting HIV may also be promoting the death of sensory nerves in the skin

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News